• KOL
    • KOLs Community
    • Personal
    • Personal Statements
    • Farzam Gorouhi
    • Farzam Gorouhi

      Farzam Gorouhi

      Department of Dermatology, The Permanente Medical Group, Northern California, Oakland | Kaiser Permanente, South Sacramento Medical Center, Sacramento, California | Department ...

       

       

      KOL Resume for Farzam Gorouhi

      Year
      2021

      Department of Dermatology, The Permanente Medical Group, Northern California, Oakland

      Kaiser Permanente, South Sacramento Medical Center, Sacramento, California

      2020

      The Permanente Medical Group, South Sacramento Medical Center, Sacramento, California

      2018

      Children's Hospital Oakland Research Institute, Oakland, California.

      2017

      From the Division of Trauma, Acute Care Surgery, and Surgical Critical Care (C.D.C., F.G., E.S.S., J.M.G.), University of California Davis School of Medicine, Sacramento, California.

      Department of Dermatology, University of California, Davis, Sacramento, CA, USA

      2016

      Department of Dermatology, University of California, 3301 C St # 1400, 95816, Davis, CA, USA

      2015

      Department of Dermatology, University of California, Davis for Farzam Gorouhi

      2014

      University of California, Davis, Sacramento, CA 95816, USA

      2013

      Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran

      Department of Dermatology, School of Medicine, University of California at Davis, Davis, California, USA.

      2012

      Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, 415 Taleghani Ave, 14166, Tehran, Iran

      2010

      Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran

      Department of Dermatology, University of California, 94143-0989, San Francisco, CA, USA

      2009

      Correspondence to: Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran

      Department of Dermatology, University of California, San Francisco, CA, USA

      2008

      Department of Medicine, The Reading Hospital and Medical Center, West Reading, PA, USA

      Center for Research and Training in Skin Diseases and Leprosy, Medical Sciences/University of Tehran, Tehran, Iran

      2007

      Center for Research and Training in Skin Diseases and Leprosy, Medical Sciences / University of Tehran, Tehran, Iran.

      Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran

      2006

      Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences (Drs Firooz, Khamesipour, Nassiri-Kashani, Khatami, Gorouhi, Rashighi-Firoozabadi, and Dowlati and Mr Eskandari), and National Office for Zoonotic Diseases, Diseases Management Center, Ministry of Health and Medical Education (Dr Hooshmand), Tehran

      2005

      Center for Research & Training in Skin Diseases & Leprosy, and

      Razi Skin Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran

       

       

      Farzam Gorouhi: Influence Statistics

      Sample of concepts for which Farzam Gorouhi is among the top experts in the world.
      Concept World rank
      pimecrolimus triamcinolone groups #2
      differential diagnosis lp #2
      triamcinolone 01 paste #2
      olp topical pimecrolimus #2
      pandemic—distinct features #2
      treatment 312 #2
      clinical subtypes lp #2
      trial pimecrolimus #2
      pandemic—distinct features adolescents #2
      antiaging topical peptides #2
      triamcinolone acetonide paste #2
      covid19 pandemic—distinct features #2
      laser dlqi #2
      prognosis lichen #2
      sessions laser treatment #2
      laser treatment conclusion #2
      differential diagnoses immunopathogenesis #2
      nonischemic eruption #2
      312 laser treatment #2
      pandemics sarscov2 toes #2
      01 paste #2
      01 paste olp #2
      triamcinolone prominent #2
      pimecrolimus measured #2
      hah attack intensity #3
      topic zinc sulfate #3
      hah newcomers #3
      hah satisfactory tolerability #3
      moderate severe hah #3
      119 study arms #3
      incidence gabapentin #3
      sickness amines #3
      olp objective #3
      performed hah #3
      hah hypobaric #3
      600 singledose #3
      hah aminobutyric acid #3
      azoles cryotherapy #3
      gsqs score #3
      prevention hypobaric #3
      background highaltitude headache #3
      reviewed trials quality #3
      gabapentin 44 431 #3
      paromomycin randomized #3
      isrctn26123577 #3
      hah gabapentin #3
      trial registration isrctn26123577 #3
      antimony azoles #3
      gabapentin capsule #3
      topical antimony #3

       

      Prominent publications by Farzam Gorouhi

      KOL-Index: 12561

      BACKGROUND: Lichen planus is a common chronic inflammatory mucocutaneous disease, affecting 0.1% to 4% of the general population. There is no published randomized active control clinical trial on pimecrolimus for the treatment of oral lichen planus (OLP).

      OBJECTIVE: The purpose of this study was to compare the efficacy and safety of pimecrolimus 1% cream with triamcinolone acetonide 0.1% paste in treating OLP.

      METHODS: In this investigator-blinded parallel-group randomized clinical ...

      Known for Lichen Planus | Pimecrolimus Cream | Triamcinolone Acetonide | Patients Olp | 2 Months
      KOL-Index: 9836

      Inflammation is one of the early phases in the development of gastric cancer. Therefore, several studies have examined the association of polymorphisms in tumour-necrosis factor-A gene (TNF-A) with gastric cancer risk. This meta-analysis reviews and summarises published evidence for these associations. Searching several databases yielded 24 independent studies that reported on the associations between TNF-A polymorphisms and gastric cancer risk. We analysed available data for the most ...

      Known for Gastric Cancer | Necrosis Factor | 95 Cis | Association Polymorphisms | Tnf Genotype
      KOL-Index: 9257

      OBJECTIVE: To compare the long-term effectiveness and safety of long-pulsed Nd:YAG and alexandrite lasers, individually and in combination, in long-term leg hair reduction.

      DESIGN: Randomized, single-center, within-participant, investigator-blinded, active-controlled clinical trial.

      SETTING: Private skin laser center.

      PARTICIPANTS: Twenty individuals aged 16 to 50 years with skin phototypes III and IV.

      INTERVENTIONS: The medial and lateral sides of each participant's legs were randomly ...

      Known for Yag Laser | Hair Reduction | Combination Therapy | Pulsed Alexandrite | Spot Size
      KOL-Index: 8722

      OBJECTIVE: To determine the efficacy and safety of imiquimod in combination with meglumine antimoniate in treating cutaneous leishmaniasis.

      DESIGN: Prospective, randomized, assessor-blind, parallel-design, placebo-controlled trial.

      SETTING: Two primary care health clinics.

      PATIENTS: One hundred nineteen patients (59 patients in the imiquimod group and 60 in the placebo group) were included in the study.

      INTERVENTIONS: Patients were randomly assigned to receive a combined 4-week course of ...

      Known for Meglumine Antimoniate | Patients Cutaneous Leishmaniasis | Clinical Cure | Leishmania Tropica | Imiquimod Combination
      KOL-Index: 8274

      The frequency of sensitization to contact allergens varies in different countries because of both genetic and, more importantly, allergen exposure variations. The objective is to determine the frequency of sensitization to contact allergens in Iranian patients with dermatitis. 250 patients with a clinical diagnosis of contact dermatitis and/or atopic dermatitis were evaluated with a 28-allergen screening series recommended by the German Contact Dermatitis Research Group from September ...

      Known for Allergic Contact Dermatitis | Nickel Sulfate | Sensitization Contact | Cobalt Chloride | Iranian Patients
      KOL-Index: 7528

      Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll-like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage-activating lipopeptide-2 (MALP2) to activate ARs and TLR2, respectively, in human bone ...

      Known for Wound Healing | Mesenchymal Stem | Adrenergic Receptors | Beta Antagonists | Cells Mice
      KOL-Index: 7366

      BACKGROUND: Unwanted facial hair can have adverse psychological effects on women and reduce their quality of life.

      OBJECTIVE: To assess the effects of unwanted facial hair removal with laser on improving quality of life.

      METHODS: In this study, 70 patients treated for unwanted facial hair by laser were assessed by Dermatology Life Quality Index (DLQI) questionnaire on admission and 3 months later after three sessions of laser treatment.

      RESULTS: The DLQI score before treatment was 9.42 ...

      Known for Laser Treatment | Hair Removal | Quality Life | Dlqi Score | Hirsutism Humans
      KOL-Index: 7202

      Stress-induced hormones can alter the inflammatory response to tissue injury; however, the precise mechanism by which epinephrine influences inflammatory response and wound healing is not well defined. Here we demonstrate that epinephrine alters the neutrophil (polymorphonuclear leukocyte (PMN))-dependent inflammatory response to a cutaneous wound. Using noninvasive real-time imaging of genetically tagged PMNs in a murine skin wound, chronic, epinephrine-mediated stress was modeled by ...

      Known for Wound Healing | Skin Stress | Inflammatory Response | Adrenergic Receptor | Current Understanding
      KOL-Index: 6133

      OBJECTIVE: To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS) and altitude headache development within 24 hours of ascent, we designed a double-blind, randomized, clinical trial.

      METHODS: A prospective, double-blind, randomized, placebo-controlled trial was conducted in Tochal Mountain Hotel at an altitude of 3,500 meters above sea level during October 2006 to November 2006. A total of 102 Iranian adults were assigned to receive either sumatriptan ...

      Known for Acute Mountain Sickness | Ams Placebo | Altitude Headache | Disease Adolescent | Receptor Agonists
      KOL-Index: 6114

      PURPOSE: To determine the time needed to reach corneal stability after discontinued daily wear of soft contact lenses and to identify corneal topographic and pachymetric changes during this period.

      METHODS: We prospectively studied the eyes of 21 consecutive soft contact lens wearers evaluated for keratorefractive surgery. Each eye was examined once immediately after lens removal, 3 and 7 days later, and weekly thereafter. At each visit, manifest refraction, keratometry, corneal ...

      Known for Contact Lens | Corneal Warpage | Hydrophilic Cornea | Refractive Surgery | Visual Acuity
      KOL-Index: 5952

      Headache is the most prevalent symptom of acute mountain sickness. We conducted a pilot clinical trial at an altitude of 3500 m to evaluate the efficacy of gabapentin in treatment of high-altitude headache (HAH). Twenty-four adult HAH patients (10 female, 14 male; age 18-50 years) were randomly assigned to receive either 300 mg of gabapentin capsule or identical placebo. After 1 h the presence of HAH and need to receive supplementary analgesic were assessed. The duration of the HAH-free ...

      Known for Altitude Headache | Gabapentin Treatment | Acute Mountain Sickness | Aminobutyric Acid | Method Female
      KOL-Index: 5419

      BACKGROUND: Pemphigus vulgaris (PV) is a severe blistering disease involving the skin and mucous membranes. The most common causes of death in these patients are adverse effects of drugs, and infection. Skin lesions are one of the important sources of infection. Thus, any local treatment that could reduce healing time of lesions and consequently reduce the total dosage of drugs needed to treat is favourable.

      OBJECTIVE: To evaluate the efficacy of epidermal growth factor (EGF) in reducing ...

      Known for Epidermal Growth Factor | Skin Lesions | Pemphigus Vulgaris | Healing Time | Total Dosage
      KOL-Index: 5279

      BACKGROUND: Cutaneous leishmaniasis (CL) is caused by different species of Leishmania and transmitted by the bite of infected sand flies. It is a health problem in many countries.

      OBJECTIVE: This study was performed to assess the evidence for the efficacy of different therapeutic modalities for acute Old World CL, which is usually caused by L major and L tropica.

      METHODS: Evidence was reviewed according to the hierarchy of evidence. Because there have been no published systematic reviews ...

      Known for Randomized Controlled | Cutaneous Leishmaniasis | Treatment Acute | Major Tropica | Health Problem
      KOL-Index: 4941

      Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal, and conjunctival mucosa. It has different variants based on the morphology of the lesions and the site of involvement. The literature suggests that certain presentations of the disease such as esophageal or ophthalmological involvement are underdiagnosed. The burden of the disease is higher ...

      Known for Lichen Planus | Clinical Subtypes | Mucous Membranes | Differential Diagnosis | Chronic Inflammatory Disorder
      KOL-Index: 4825

      Chronic venous leg ulcers are profoundly debilitating and result in billions in health care expenditure. Thus, there is a quest for engineered and innovative approaches. Herein we present a 63-year-old patient with a 30 year history of venous stasis and left lower extremity ulcers, which have been refractory to standard of care, anticoagulation and venous stripping. The medial ulcer was treated with transplantation of autologous adipose mesenchymal stem cell (AMSC)-enriched, high-density ...

      Known for Topical Timolol | Mesenchymal Stem | Chronic Wounds | Wound Healing | Venous Leg

      Key People For Personal Statements

      Top KOLs in the world
      #1
      Mohsen M Shabahang
      national cancer database general surgery gastric cancer
      #2
      Mark Sadoski
      medical students mental imagery physical practice
      #3
      Scott Thomas
      personal statement simulation curriculum surgery residency
      #4
      Bobbie Ann Adair White
      pleural infections explicit bias personal statement
      #5
      Scott B Segal
      epidural analgesia cesarean delivery obstetric anesthesia
      #6
      Brian J Gelfand
      personal statements residency application essays evidence plagiarism

      Farzam Gorouhi:Expert Impact

      Concepts for whichFarzam Gorouhihas direct influence:Personal statements,  Allergic contact dermatitis,  Contact dermatitis,  Cutaneous manifestations,  Yag laser,  Meglumine antimoniate,  Aging skin,  Laser treatment.

      Farzam Gorouhi:KOL impact

      Concepts related to the work of other authors for whichfor which Farzam Gorouhi has influence:Lichen planus,  Cutaneous leishmaniasis,  Gastric cancer,  Striae gravidarum,  Wound healing,  Pemphigus vulgaris,  Seborrheic dermatitis.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Department of Dermatology, The Permanente Medical Group, Northern California, Oakland | Kaiser Permanente, South Sacramento Medical Center, Sacramento, California | Department of Dermatology, University of California, Davis | The Permanente Medical G

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.